All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 Co-optees Name Role Darren Green Consultant Nephrologist and Acute Physician, Salford Royal Foundation Trust Hasnain Dalal Senior Clinical Researcher, Royal Cornwall Hospitals; Honorary Clinical Associate Professor, University of Exeter Medical School Suzanne Kite Palliative Care Physician Kath Measures Clinical Specialist Physiotherapist in Cardiology Simon Corbett Consultant Cardiologist, University Hospital Southampton Rod Taylor Professor in Health Services Research (Medical Statistics & Clinical Trials), Director of Exeter Clinical Trials Unit Peer reviewers Name Role Martin Cowie Honorary Consultant, Cardiologist, Royal Brompton & Harefield NHS Trust Chronic Heart Failure Acknowledgements NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 Acknowledgements The development of this guideline was greatly assisted by the following people: Professor Martin Cowie for reviewing the economic model methodology section prior to running the sensitivity analyses. Chronic Heart Failure Guideline summary NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 1 Guideline summary 1.1 Full list of recommendations 1. Take a careful and detailed history, and perform a clinical examination and tests to confirm the presence of heart failure. [2010] 2. Measure N-terminal pro-B-type natriuretic peptide [NT-proBNP] in people with suspected heart failure. [2018] 3. Because very high levels of NT-proBNP carry a poor prognosis, refer people with suspected heart failure and an NT-proBNP level above 2,000 ng/litre (236 pmol/litre) urgently, to have specialist assessment and transthoracic echocardiography within 2 weeks. [ 2018] 4. Refer people with suspected heart failure and an NT-proBNP level between 400 and 2,000 ng/litre (47 to 236 pmol/litre) to have specialist assessment and transthoracic echocardiography within 6 weeks. [2018] 5. 